drugset / Trial / NCT01666743

Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial Pneumonia

NCT01666743

Phase 4 Withdrawn Forest Laboratories
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety and efficacy of ceftaroline fosamil in elderly subjects with community-acquired bacterial pneumonia (CABP) receiving antibiotic therapy in the hospital.

Timeline

Start
2012-11
Primary completion
2013-09
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ceftaroline fosamil Other / unclassified 600 mg Intravenous

Indications